New Device Detects Stage I Cancer in Blood

A new device, built around a revolutionary, proprietary nanosensor uses volatile organic compounds found in blood, urine, saliva and sweat to detect disease. Ovarian cancer has been successfully detected in 58 lab-bench tests at the University of Pennsylvania with 95% sensitivity and 99% specificity.